Effects of long-acting alendronate on osteoporosis with impaired glucose metabolism
Phase 4
- Conditions
- Osteoporosis
- Registration Number
- JPRN-UMIN000000987
- Lead Sponsor
- ational Hospital Organization, Kyoto Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1) patient taking bisphosphonates 2) patients contraindicated for alendronate 3) patients under treatment of glucocorticoid or with a history of treatment for 3 years or more. 4) disease states causing secondary osteoporosis: primary hyperparathyroidism, hyperthyroidism, hypogonadism, chronic rheumatic arthritis, multiple myeloma and other hematological diseases,Cushing's syndrome, immobilization, mesotholexate 5) type I diabetes mellitus, diabetes associated with other specific diseases and pregnancy 6) patients not suitable for measuring bone mineral density due to the history of supine bone fracture 7) other various conditions in which the attending doctor decide not suitable for entry.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method